MATA NATHAN L. (Chief Scientific Officer) sold 666.00 shares of BELITE BIO, INC on the open market
Open‑market sale worth $102.0K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 5/8/2026ACC: 0001193125-26-214820
Officer· Chief Scientific Officer
Since Mar 2026
-666.00
Net shares
Net seller
$102.0K
Total sold
4
Open market trades
0B · 4S
4
Total transactions
666.00 disposed
Non-Derivative Transactions4
American depositary share
Direct
Shares
−226.00
Price / share
$152.45
Trade value
$34.45K
% of position
33.9%
5/7/2026
666.00→440.00
American depositary share
Direct
Shares
−428.00
Price / share
$153.56
Trade value
$65.73K
% of position
97.3%
5/7/2026
440.00→12.00
American depositary share
Direct
Shares
−3.00
Price / share
$154.61
Trade value
$463.83
% of position
25.0%
5/7/2026
12.00→9.00
American depositary share
Direct
Shares
−9.00
Price / share
$155.25
Trade value
$1.40K
% of position
New position
5/7/2026
9.00→0.00
Total
Net shares
−666.00
Net value
-$102.04K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| American depositary share Direct | 5/7/2026 | S · Sale | −226.00 | $152.45 | $34.45K | 33.9% | 666.00 | 440.00 |
| American depositary share Direct | 5/7/2026 | S · Sale | −428.00 | $153.56 | $65.73K | 97.3% | 440.00 | 12.00 |
| American depositary share Direct | 5/7/2026 | S · Sale | −3.00 | $154.61 | $463.83 | 25.0% | 12.00 | 9.00 |
| American depositary share Direct | 5/7/2026 | S · Sale | −9.00 | $155.25 | $1.40K | New position | 9.00 | 0.00 |
| Total | −666.00 | -$102.04K | ||||||
Derivative Transactions0
No derivative transactions reported